SCM
SGMO

Sio Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sio Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-395,496
Closed -$2.39M – 52
2016
Q1 		$2.39M Buy
+395,496
New +$2.37M 0.88% 31

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sio Capital Management's SGMO Position: Q2 2016 in Review

Sio Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2016, closing a stake of 395,496 shares — an estimated $2.39M sold.

Sio Capital Management first reported a position in SGMO in Q1 2016 and held it in 1 quarter. The position peaked at $2.39M in Q1 2016. 136 funds tracked by Wall St. Rank hold SGMO as of Q2 2016.

  • Sio Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
  • Sio Capital Management sold 395,496 SANGAMO THERAPEUTICS INC shares in Q2 2016, an estimated $2.39M.
  • Sio Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2016 and held it in 1 quarter.
  • Sio Capital Management's SANGAMO THERAPEUTICS INC position peaked at $2.39M in Q1 2016.
  • 136 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2016.

Based on Sio Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.